Proteros biostructures and Orion Pharma agree on a long-term multi-target collaboration including the assembly of a joint novel and unique HTS small-molecule screening library with the full chemistry support of Enamine

Written by Kirsten Ruehl on 6th September 2023. Posted in Client News.